Clinical Trial

Hypertonic Lactate After Cardiac Arrest

Study acronym: LATTE
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-08-09; most recent amendment 2025-02-20.
Status change: Active, Not Recruiting → Recruiting 2025-02-20
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-02-18
Trial Details
NCT Number NCT05004610
Lead Sponsor Erasme University Hospital
Conditions Cardiac Arrest, Ischemia Reperfusion Injury, Anoxic Brain Injury
Enrollment 125 participants
Start Date 2025-02-19
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-05-15 (estimated)
Updated on ClinicalTrials.gov 2025-02-21